ID   TPC_HUMAN               Reviewed;         320 AA.
AC   Q9HC21; E9PF74; Q6V9R7;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   07-APR-2021, entry version 177.
DE   RecName: Full=Mitochondrial thiamine pyrophosphate carrier;
DE   AltName: Full=Mitochondrial uncoupling protein 1;
DE   AltName: Full=Solute carrier family 25 member 19;
GN   Name=SLC25A19; Synonyms=DNC, MUP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHARACTERIZATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=11226231; DOI=10.1073/pnas.031430998;
RA   Dolce V., Fiermonte G., Runswick M.J., Palmieri F., Walker J.E.;
RT   "The human mitochondrial deoxynucleotide carrier and its role in the
RT   toxicity of nucleoside antivirals.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:2284-2288(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Renard S., Mondesert G., Besnard F.;
RT   "MUP 1, a mitochondrial uncoupling protein.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Li H., Yu R., Zhou G., Ke R., Shen C., Lin L., Yang S.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=18280798; DOI=10.1016/j.mito.2008.01.001;
RA   Kang J., Samuels D.C.;
RT   "The evidence that the DNC (SLC25A19) is not the mitochondrial
RT   deoxyribonucleotide carrier.";
RL   Mitochondrion 8:103-108(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [10]
RP   VARIANT MCPHA ALA-177.
RX   PubMed=12185364; DOI=10.1038/ng948;
RA   Rosenberg M.J., Agarwala R., Bouffard G., Davis J., Fiermonte G.,
RA   Hilliard M.S., Koch T., Kalikin L.M., Makalowska I., Morton D.H.,
RA   Petty E.M., Weber J.L., Palmieri F., Kelley R.I., Schaeffer A.A.,
RA   Biesecker L.G.;
RT   "Mutant deoxynucleotide carrier is associated with congenital
RT   microcephaly.";
RL   Nat. Genet. 32:175-179(2002).
RN   [11]
RP   VARIANT THMD4 SER-125, AND CHARACTERIZATION OF VARIANT THMD4 SER-125.
RX   PubMed=19798730; DOI=10.1002/ana.21752;
RA   Spiegel R., Shaag A., Edvardson S., Mandel H., Stepensky P., Shalev S.A.,
RA   Horovitz Y., Pines O., Elpeleg O.;
RT   "SLC25A19 mutation as a cause of neuropathy and bilateral striatal
RT   necrosis.";
RL   Ann. Neurol. 66:419-424(2009).
CC   -!- FUNCTION: Mitochondrial transporter mediating uptake of thiamine
CC       pyrophosphate (ThPP) into mitochondria. {ECO:0000269|PubMed:18280798}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HC21-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HC21-2; Sequence=VSP_053908;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined except for
CC       placenta. Highest levels in colon, kidney, lung, testis, spleen, and
CC       brain. {ECO:0000269|PubMed:11226231}.
CC   -!- DISEASE: Microcephaly, Amish type (MCPHA) [MIM:607196]: A disorder
CC       characterized by severe congenital microcephaly and severe 2-
CC       ketoglutaric aciduria leading to death within the first year.
CC       {ECO:0000269|PubMed:12185364}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Thiamine metabolism dysfunction syndrome 4, bilateral striatal
CC       degeneration and progressive polyneuropathy type (THMD4) [MIM:613710]:
CC       A disease characterized by recurrent episodes of flaccid paralysis and
CC       encephalopathy associated with bilateral striatal necrosis and chronic
CC       progressive polyneuropathy. {ECO:0000269|PubMed:19798730}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: The transmembrane helices are not perpendicular to the
CC       plane of the membrane, but cross the membrane at an angle. Odd-numbered
CC       transmembrane helices exhibit a sharp kink, due to the presence of a
CC       conserved proline residue (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ251857; CAC27560.1; -; mRNA.
DR   EMBL; AJ301616; CAC37793.1; -; Genomic_DNA.
DR   EMBL; AF182404; AAG16903.1; -; mRNA.
DR   EMBL; AY346372; AAQ54327.1; -; mRNA.
DR   EMBL; AC022211; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001075; AAH01075.1; -; mRNA.
DR   EMBL; BC005120; AAH05120.1; -; mRNA.
DR   CCDS; CCDS11720.1; -. [Q9HC21-1]
DR   RefSeq; NP_001119593.1; NM_001126121.1. [Q9HC21-1]
DR   RefSeq; NP_001119594.1; NM_001126122.1. [Q9HC21-1]
DR   RefSeq; NP_068380.3; NM_021734.4. [Q9HC21-1]
DR   RefSeq; XP_005257616.1; XM_005257559.3. [Q9HC21-1]
DR   RefSeq; XP_005257617.1; XM_005257560.2. [Q9HC21-1]
DR   RefSeq; XP_005257618.1; XM_005257561.3. [Q9HC21-1]
DR   RefSeq; XP_005257619.1; XM_005257562.2. [Q9HC21-1]
DR   RefSeq; XP_006722070.1; XM_006722007.2. [Q9HC21-1]
DR   RefSeq; XP_016880415.1; XM_017024926.1. [Q9HC21-1]
DR   SMR; Q9HC21; -.
DR   BioGRID; 121903; 28.
DR   IntAct; Q9HC21; 19.
DR   MINT; Q9HC21; -.
DR   STRING; 9606.ENSP00000385312; -.
DR   TCDB; 2.A.29.16.1; the mitochondrial carrier (mc) family.
DR   iPTMnet; Q9HC21; -.
DR   PhosphoSitePlus; Q9HC21; -.
DR   SwissPalm; Q9HC21; -.
DR   BioMuta; SLC25A19; -.
DR   DMDM; 20137652; -.
DR   EPD; Q9HC21; -.
DR   jPOST; Q9HC21; -.
DR   MassIVE; Q9HC21; -.
DR   MaxQB; Q9HC21; -.
DR   PaxDb; Q9HC21; -.
DR   PeptideAtlas; Q9HC21; -.
DR   PRIDE; Q9HC21; -.
DR   ProteomicsDB; 20044; -.
DR   ProteomicsDB; 81625; -. [Q9HC21-1]
DR   Antibodypedia; 46024; 102 antibodies.
DR   DNASU; 60386; -.
DR   Ensembl; ENST00000320362; ENSP00000319574; ENSG00000125454. [Q9HC21-1]
DR   Ensembl; ENST00000375261; ENSP00000364410; ENSG00000125454. [Q9HC21-2]
DR   Ensembl; ENST00000402418; ENSP00000385312; ENSG00000125454. [Q9HC21-1]
DR   Ensembl; ENST00000416858; ENSP00000397818; ENSG00000125454. [Q9HC21-1]
DR   Ensembl; ENST00000442286; ENSP00000402202; ENSG00000125454. [Q9HC21-1]
DR   Ensembl; ENST00000580994; ENSP00000463795; ENSG00000125454. [Q9HC21-1]
DR   GeneID; 60386; -.
DR   KEGG; hsa:60386; -.
DR   UCSC; uc002jns.5; human. [Q9HC21-1]
DR   CTD; 60386; -.
DR   DisGeNET; 60386; -.
DR   GeneCards; SLC25A19; -.
DR   GeneReviews; SLC25A19; -.
DR   HGNC; HGNC:14409; SLC25A19.
DR   HPA; ENSG00000125454; Tissue enhanced (testis).
DR   MalaCards; SLC25A19; -.
DR   MIM; 606521; gene.
DR   MIM; 607196; phenotype.
DR   MIM; 613710; phenotype.
DR   neXtProt; NX_Q9HC21; -.
DR   OpenTargets; ENSG00000125454; -.
DR   Orphanet; 99742; Amish lethal microcephaly.
DR   Orphanet; 217396; Progressive polyneuropathy with bilateral striatal necrosis.
DR   PharmGKB; PA37879; -.
DR   VEuPathDB; HostDB:ENSG00000125454.11; -.
DR   eggNOG; KOG0752; Eukaryota.
DR   GeneTree; ENSGT00550000074902; -.
DR   HOGENOM; CLU_015166_10_3_1; -.
DR   InParanoid; Q9HC21; -.
DR   OMA; QFWSYEQ; -.
DR   PhylomeDB; Q9HC21; -.
DR   TreeFam; TF313047; -.
DR   PathwayCommons; Q9HC21; -.
DR   Reactome; R-HSA-196819; Vitamin B1 (thiamin) metabolism.
DR   BioGRID-ORCS; 60386; 104 hits in 998 CRISPR screens.
DR   GeneWiki; SLC25A19; -.
DR   GenomeRNAi; 60386; -.
DR   Pharos; Q9HC21; Tbio.
DR   PRO; PR:Q9HC21; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q9HC21; protein.
DR   Bgee; ENSG00000125454; Expressed in testis and 194 other tissues.
DR   ExpressionAtlas; Q9HC21; baseline and differential.
DR   Genevisible; Q9HC21; HS.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0030233; F:deoxynucleotide transmembrane transporter activity; TAS:UniProtKB.
DR   GO; GO:0015234; F:thiamine transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0030302; P:deoxynucleotide transport; NAS:UniProtKB.
DR   GO; GO:0030974; P:thiamine pyrophosphate transmembrane transport; IBA:GO_Central.
DR   GO; GO:0042723; P:thiamine-containing compound metabolic process; TAS:Reactome.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR002067; Mit_carrier.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom_sf.
DR   Pfam; PF00153; Mito_carr; 3.
DR   PRINTS; PR00926; MITOCARRIER.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Membrane; Mitochondrion;
KW   Mitochondrion inner membrane; Neuropathy; Phosphoprotein;
KW   Reference proteome; Repeat; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..320
FT                   /note="Mitochondrial thiamine pyrophosphate carrier"
FT                   /id="PRO_0000090611"
FT   TRANSMEM        19..39
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        87..107
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        122..142
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        173..193
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        220..240
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        293..313
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          13..106
FT                   /note="Solcar 1"
FT   REPEAT          116..202
FT                   /note="Solcar 2"
FT   REPEAT          214..309
FT                   /note="Solcar 3"
FT   MOTIF           241..246
FT                   /note="Substrate recognition"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         97..153
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_053908"
FT   VARIANT         125
FT                   /note="G -> S (in THMD4; affects function as shown by
FT                   complementation studies in yeast; dbSNP:rs387906944)"
FT                   /evidence="ECO:0000269|PubMed:19798730"
FT                   /id="VAR_065125"
FT   VARIANT         177
FT                   /note="G -> A (in MCPHA; dbSNP:rs119473030)"
FT                   /evidence="ECO:0000269|PubMed:12185364"
FT                   /id="VAR_014103"
FT   CONFLICT        186
FT                   /note="F -> L (in Ref. 3; AAQ54327)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   320 AA;  35511 MW;  57CE0F01D538B1BE CRC64;
     MVGYDPKPDG RNNTKFQVAV AGSVSGLVTR ALISPFDVIK IRFQLQHERL SRSDPSAKYH
     GILQASRQIL QEEGPTAFWK GHVPAQILSI GYGAVQFLSF EMLTELVHRG SVYDAREFSV
     HFVCGGLAAC MATLTVHPVD VLRTRFAAQG EPKVYNTLRH AVGTMYRSEG PQVFYKGLAP
     TLIAIFPYAG LQFSCYSSLK HLYKWAIPAE GKKNENLQNL LCGSGAGVIS KTLTYPLDLF
     KKRLQVGGFE HARAAFGQVR RYKGLMDCAK QVLQKEGALG FFKGLSPSLL KAALSTGFMF
     FSYEFFCNVF HCMNRTASQR
//
